What is the main difference between Epithalon and Ventfort?

Epithalon is a Longevity peptide while Ventfort is a Other peptide. Epithalon has Low evidence (28 sources) and Ventfort has Very Low evidence (6 sources).

Which has more clinical evidence, Epithalon or Ventfort?

Epithalon has more clinical evidence with 5 human studies compared to 0 for Ventfort. Overall, Epithalon has Low evidence strength while Ventfort has Very Low.

Are Epithalon and Ventfort FDA approved?

Epithalon has Low clinical evidence and is not FDA-approved for general use. Ventfort has Very Low clinical evidence and is not FDA-approved for general use. Always verify current regulatory status with official sources.

Can Epithalon and Ventfort be combined?

There is no published research on combining Epithalon and Ventfort. The safety and efficacy of any combination is unknown without clinical data.

Longevity Comparison

Epithalon vs Ventfort

Comparison of Epithalon (Low evidence) and Ventfort (Very Low evidence).

Last updated: February 12, 2026

Epithalon

Low Evidence

View full dossier

Ventfort

Very Low Evidence

View full dossier

Overview

Epithalon and Ventfort are both studied in the peptide research space.

Epithalon: A synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed by Russian scientist Vladimir Khavinson, claimed to activate telomerase and extend lifespan.

Ventfort: A cytamin-class peptide supplement derived from blood vessel tissue, part of the Russian bioregulator framework.

Evidence Comparison

Aspect	Epithalon	Ventfort
Evidence Level	Low	Very Low
Human Studies	5	0
Preclinical Studies	15	5
Total Sources	28	6

Key Differences

Aspect	Epithalon	Ventfort
Category	Longevity	Other
Evidence Strength	Low	Very Low
Total Sources	28	6
Human Studies	5	0

Summary

Epithalon: Low evidence with 28 total sources (5 human)
Ventfort: Very Low evidence with 6 total sources (0 human)

This comparison is for educational purposes only and is not medical advice. Consult a healthcare professional before making any decisions about peptide use.

View Full Dossiers

Epithalon Evidence Dossier Ventfort Evidence Dossier

Stay Updated on Peptide Comparisons

Get notified when we publish new comparison dossiers and evidence reviews.

No spam. Unsubscribe anytime.

Disclaimer: This comparison is for educational purposes only and does not constitute medical advice. Individual responses to medications vary. Always consult a qualified healthcare provider before making treatment decisions.